slim-bayesian
Evaluation of Bayesian optimization to select predictive models of acute infection and in-hospital mortality
Gallery

Evaluation of Bayesian optimization to select predictive models of acute infection and in-hospital mortality

, ,

Evaluation of Bayesian optimization to select predictive models of acute infection and in-hospital mortality

, ,
2022-06-01T17:18:14-07:00

Mayhew, M. et al. Pac Symp Biocomput. Jan 2021.

Man masked with covid kit
Cost impact model of a novel multi-mRNA host response assay for diagnosis and risk assessment of acute infections and sepsis in the ED
Gallery

Cost impact model of a novel multi-mRNA host response assay for diagnosis and risk assessment of acute infections and sepsis in the ED

,

Cost impact model of a novel multi-mRNA host response assay for diagnosis and risk assessment of acute infections and sepsis in the ED

,
2021-07-09T11:11:02-07:00

Schneider JE, Romanowsky J, et al. JHEOR. 2020.

Inflammatix is reimagining diagnostics by developing rapid tests that read the immune system to resolve major clinical and public health challenges. Our initial focus is on acute bacterial and viral infections, and sepsis.

We’re seeking teammates with expertise, curiosity and passion for solving clinical challenges with a focus on patient outcomes. If that sounds like you, check out our Careers Page.

Close up of hand holding briefcase and face mask

© Copyright, Inflammatix, Inc.     All Rights Reserved   |   Terms & Conditions   |   Privacy & Cookies Statement
Inflammatix, TriVerity and BacVerity are trademarks of Inflammatix, Inc.

Go to Top